Oncternal Therapeutics Competitors and Similar CompaniesClear all
Oncternal Therapeutics's competitors and similar companies include Neovii, ImmPACT-Bio, Coherus Oncology and Gossamer Bio.
 Oncternal Therapeutics Oncternal Therapeutics is a clinical-stage biopharmaceutical company focused on developing oncology therapies. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. | |
Founding Date | Founding Date 1997 | Founding Date 2003 | Founding Date 2017 | Founding Date 2010 | Founding Date 2015 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Sonoma, US HQ | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL | Locations Redwood City, US HQ Camarillo, US | Locations San Diego, US HQ Dublin 2, IE |
Employees | Employees 2710% decrease | Employees 1193% increase | Employees 845% decrease | Employees 14736% decrease | Employees 11820% increase |
Valuation ($) | Valuation ($) 4.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 85.6 m | Valuation ($) 208 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $785k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) |
Net income | Net income ($39.5m) (FY, 2023) | Net income N/A | Net income N/A | Net income $168m (FY, 2025) | Net income ($170.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 18.6m | Total funding raised N/A | Total funding raised $ 18m | Total funding raised $ 174.5m | Total funding raised $ 480m |
For sources of this data, please see the company profile
View Company Profiles
Neovii
HQ
Rapperswil-Jona, CH
Employees
119↑ 3% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View companyCoherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyGossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View company